Published in Curr Alzheimer Res on January 01, 2015
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol (2010) 19.42
Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol Rev (1992) 14.45
Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology (1974) 7.34
Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology (2001) 5.98
Measures of brain morphology and infarction in the framingham heart study: establishing what is normal. Neurobiol Aging (2005) 5.84
The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex (2008) 5.36
Cerebral MRI findings and cognitive functioning: the Atherosclerosis Risk in Communities study. Neurology (2005) 3.21
Rates of dementia in three ethnoracial groups. Int J Geriatr Psychiatry (1999) 2.92
Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch Neurol (2008) 2.69
Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch Neurol (2005) 2.39
The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. Neuroepidemiology (1997) 2.31
Validity of self-reported stroke in elderly African Americans, Caribbean Hispanics, and Whites. Arch Neurol (2009) 2.05
Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults. J Neurosci (2012) 1.76
MRI predictors of cognitive change in a diverse and carefully characterized elderly population. Neurobiol Aging (2010) 1.56
Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community. Arch Neurol (2012) 1.44
Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter? Dialogues Clin Neurosci (2009) 1.38
Do neuropsychological tests have the same meaning in Spanish speakers as they do in English speakers? Neuropsychology (2010) 1.37
Brain behavior relationships among African Americans, whites, and Hispanics. Alzheimer Dis Assoc Disord (2008) 1.30
Quantitative approaches for assessment of white matter hyperintensities in elderly populations. Psychiatry Res (2011) 1.22
Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's disease. Alzheimers Dement (2012) 1.11
Apolipoprotein E-associated risk for Alzheimer's disease in the African-American population is genotype dependent. Ann Neurol (1997) 1.06
The association of magnetic resonance imaging measures with cognitive function in a biracial population sample. Arch Neurol (2010) 1.05
Presence and progression of white matter hyperintensities and cognition: a meta-analysis. Neurology (2014) 1.00
Regional white matter hyperintensities: aging, Alzheimer's disease risk, and cognitive function. Neurobiol Aging (2013) 1.00
A quantitative systematic review of domain-specific cognitive impairment in lacunar stroke. Neurology (2013) 0.96
Differences in cognitive profile between TIA, stroke and elderly memory research subjects: a comparison of the MMSE and MoCA. Cerebrovasc Dis (2012) 0.95
Extreme deep white matter hyperintensity volumes are associated with African American race. Cerebrovasc Dis (2014) 0.91
Persistent cognitive impairment after transient ischemic attack. Stroke (2014) 0.88
Processing speed in normal aging: effects of white matter hyperintensities and hippocampal volume loss. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2013) 0.88
Neuroanatomical correlates of cognitive performance in late life. Dement Geriatr Cogn Disord (2011) 0.82
Race and health care. J S C Med Assoc (1999) 0.78
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.26
Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med (2012) 14.14
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet (2007) 9.80
National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke (2006) 6.94
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord (2009) 5.50
Genomewide association studies of stroke. N Engl J Med (2009) 5.29
Apolipoprotein E, Alzheimer disease, and African Americans. Arch Neurol (2003) 4.63
Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke (2004) 4.56
Mediterranean diet and risk for Alzheimer's disease. Ann Neurol (2006) 4.38
Epidemiology of Alzheimer disease. Nat Rev Neurol (2011) 4.13
Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol (2003) 3.75
Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke (2010) 3.75
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
Vascular cognitive impairment. Lancet Neurol (2003) 3.73
Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA (2009) 3.62
Hypertension and the risk of mild cognitive impairment. Arch Neurol (2007) 3.62
A summary risk score for the prediction of Alzheimer disease in elderly persons. Arch Neurol (2010) 3.52
Stroke and the risk of Alzheimer disease. Arch Neurol (2003) 3.49
Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry (2006) 3.44
Mediterranean diet and mild cognitive impairment. Arch Neurol (2009) 3.40
Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol (2008) 3.39
Imaging hippocampal function across the human life span: is memory decline normal or not? Ann Neurol (2002) 3.34
Genetic variation in white matter hyperintensity volume in the Framingham Study. Stroke (2004) 3.13
Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families. PLoS One (2012) 3.11
Mediterranean diet, Alzheimer disease, and vascular mediation. Arch Neurol (2006) 2.98
Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol (2010) 2.91
Alcohol intake and risk of dementia. J Am Geriatr Soc (2004) 2.90
Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity. Mov Disord (2005) 2.88
Hyperinsulinemia and risk of Alzheimer disease. Neurology (2004) 2.87
Relation of diabetes to mild cognitive impairment. Arch Neurol (2007) 2.86
Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study. Stroke (2008) 2.84
Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition. Arch Neurol (2006) 2.79
Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center. Neurology (2005) 2.76
Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol (2008) 2.71
Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch Neurol (2008) 2.69
Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. JAMA (2013) 2.58
Earlier onset of Alzheimer disease symptoms in latino individuals compared with anglo individuals. Arch Neurol (2005) 2.54
Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. Arch Neurol (2006) 2.46
Framingham stroke risk profile and lowered cognitive performance. Stroke (2004) 2.46
Mediterranean diet and Alzheimer disease mortality. Neurology (2007) 2.45
Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community. Arch Neurol (2005) 2.39
Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol (2011) 2.37
Caloric intake and the risk of Alzheimer disease. Arch Neurol (2002) 2.28
Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch Neurol (2009) 2.26
Heritability of lobar brain volumes in twins supports genetic models of cerebral laterality and handedness. Proc Natl Acad Sci U S A (2002) 2.24
Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants. PLoS Genet (2012) 2.23
The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort. Arch Neurol (2007) 2.21
Shorter telomeres are associated with mortality in those with APOE epsilon4 and dementia. Ann Neurol (2006) 2.21
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Ann Neurol (2012) 2.20
Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol (2003) 2.20
Effects of systolic blood pressure on white-matter integrity in young adults in the Framingham Heart Study: a cross-sectional study. Lancet Neurol (2012) 2.17
GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron (2013) 2.13
Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol (2004) 2.09
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Association of glucocerebrosidase mutations with dementia with lewy bodies. Arch Neurol (2009) 2.06
Validity of self-reported stroke in elderly African Americans, Caribbean Hispanics, and Whites. Arch Neurol (2009) 2.05
Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genet (2011) 2.02
SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk. Ann Neurol (2011) 2.01
Cardiovascular risk factors and Alzheimer's disease. Curr Atheroscler Rep (2004) 2.00
Comprehensive search for Alzheimer disease susceptibility loci in the APOE region. Arch Neurol (2012) 1.97
Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS). Stroke (2007) 1.96
Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study. Stroke (2004) 1.96
Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative. Arch Neurol (2010) 1.94
Intensity non-uniformity correction using N3 on 3-T scanners with multichannel phased array coils. Neuroimage (2007) 1.93
The brain in the age of old: the hippocampal formation is targeted differentially by diseases of late life. Ann Neurol (2008) 1.92
Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study. Stroke (2005) 1.91
Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Arch Neurol (2005) 1.91
Association of higher levels of high-density lipoprotein cholesterol in elderly individuals and lower risk of late-onset Alzheimer disease. Arch Neurol (2010) 1.91
Dietary factors and Alzheimer's disease. Lancet Neurol (2004) 1.90
Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clin Investig (Lond) (2012) 1.90
Measures of adiposity and dementia risk in elderly persons. Arch Neurol (2007) 1.88
White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility. Stroke (2008) 1.84
Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease. Proc Natl Acad Sci U S A (2008) 1.84
Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol (2010) 1.80
Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet (2012) 1.79
White matter hyperintensity penumbra. Stroke (2011) 1.78
Disparities in the recording of Parkinson's disease on death certificates. Mov Disord (2005) 1.75
Health and function of participants in the Long Life Family Study: A comparison with other cohorts. Aging (Albany NY) (2011) 1.74
Cognition assessment using the NIH Toolbox. Neurology (2013) 1.73
Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial. J Mol Neurosci (2002) 1.69
Radial width of the temporal horn: a sensitive measure in Alzheimer disease. AJNR Am J Neuroradiol (2002) 1.66
Education does not slow cognitive decline with aging: 12-year evidence from the victoria longitudinal study. J Int Neuropsychol Soc (2011) 1.66